Natural History Study of SCID Disorders



Status:Recruiting
Conditions:Other Indications, Infectious Disease, HIV / AIDS, Ocular, Women's Studies
Therapuetic Areas:Immunology / Infectious Diseases, Ophthalmology, Other, Reproductive
Healthy:No
Age Range:Any
Updated:11/23/2018
Start Date:August 2010
End Date:August 2019

Use our guide to learn which trials are right for you!

A Prospective Natural History Study of Diagnosis, Treatment and Outcomes of Children With SCID Disorders (RDCRN PIDTC-6901)

This study is a prospective evaluation of children with Severe Combined Immune Deficiency
(SCID) who are treated under a variety of protocols used by participating institutions. In
order to determine the patient, recipient and transplant-related variables that are most
important in determining outcome, study investigators will uniformly collect pre-, post- and
peri-transplant (or other treatment) information on all children enrolled into this study.

Children will be divided into three strata:

- Stratum A: Typical SCID with virtual absence of autologous T cells and poor T cell
function

- Stratum B: Atypical SCID (leaky SCID, Omenn syndrome and reticular dysgenesis with
limited T cell diversity or number and reduced function), and

- Stratum C: ADA deficient SCID and XSCID patients receiving alternative therapy including
PEG-ADA ERT or gene therapy.

Each Group/Cohort Stratum will be analyzed separately.

This study follows participants with SCID prospectively, meaning the study enrolls
participants where there is a plan to receive a blood and marrow transplant, enzyme therapy,
or gene therapy in the future. Participants are then followed according to a schedule set out
by the study protocol after the procedure. There are no experimental therapies on this study.

The study plans to enroll over 540 participants with SCID. By studying new participants
undergoing treatment for SCID, the goal is to learn more about: (1) outcomes from the
treatment of SCID in the modern era of medicine (2) what factors lead to the best long-term
outcomes, such as best donor, conditioning regimen, timing of transplant, etc., and (3) what
impact newborn screening and the early diagnosis of SCID has had on the long-term outcomes
following BMT or gene therapy. Information is also being gathered on how and when the immune
system recovers after bone marrow transplant (BMT), quality of life for long-term survivors,
and about whether children develop normally after treatment.

This natural history study is the largest coordinated prospective study of participants with
SCID ever performed. Information that investigators will learn, both now and in the future,
will help doctors and other health professionals to better treat children with SCID.

Inclusion Criteria:

Stratum A: Typical SCID (formerly referred to as Classic SCID)- -Subjects who meet the
following inclusion criteria and the intention is to treat with allogeneic hematopoietic
cell transplant (HCT) are eligible for enrollment into Stratum A (Typical SCID) of the
study:

- Absence or very low number of T cells (CD3 T cells <300/microliter) AND

- No or very low T cell function (<10% of lower limit of normal) as measured by response
to phytohemagglutinin (PHA) OR

- T cells of maternal origin present.

Stratum B: Leaky SCID, Omenn Syndrome, Reticular Dysgenesis-

-Subjects who meet the following criteria and the intention is to treat with HCT are
eligible for enrollment into Stratum B:

Leaky SCID:

- Maternal lymphocytes tested for and not detected AND

- Either one or both of the following (a,b) :

- a.) <50% of lower limit of normal T cell function as measured by response to PHA,
OR response to anti-CD3/CD28 antibody

- b.) Absent or <30% of lower limit of normal proliferative responses to candida
and tetanus toxoid antigens

- AND at least two of the following (a through e):

- a.) Reduced number of CD3 T cells

- age ≤2 years: <1500/microliter

- age >2 years and ≤4 years: <800/microliter

- age >4 years: <600/microliter

- b.) ≥80% of CD3+ or CD4+ T cells that are CD45RO+

- AND/OR >80% of CD3+ or CD4+ T cells are CD62L negative

- AND/OR >50% of CD3+ or CD4+T cells express HLA-DR (at <4 years of age)

- AND/OR are oligoclonal T cells

- c.) Hypomorphic mutation in IL2RG in a male, or homozygous hypomorphic mutation
or compound heterozygosity with ≥1 hypomorphic mutation in an autosomal
SCID-causing gene

- d.) Low T Cell Receptor Excision Circles (TRECs) and/or the percentage of
CD4+/45RA+/CD31+ or CD4+/45RA+/CD62L+ cells is below the lower limit of normal.

- e.) Functional testing in vitro supporting impaired, but not absent, activity of
the mutant protein, AND

- Does not meet criteria for Omenn Syndrome.

Omenn Syndrome:

- Generalized skin rash

- Maternal lymphocytes tested for and not detected;

--Note: If maternal engraftment was not assessed and ruled out, the subject is not
eligible as Omenn Syndrome.

- ≥80% of CD3+ or CD4+ T cells are CD45RO+ AND/OR

- 80% of CD3+ or CD4+T cells are CD62L negative AND/OR

- 50% of CD3+ or CD4+ T cells express HLA-DR (at <2 years of age);

- Absent or low (< 30% lower limit of normal) T cell proliferation response to antigens
(Candida, tetanus) to which the subject has been exposed

NOTE: If proliferation to antigen was not performed, but at least 4 of the following 9
supportive criteria, at least one of which must be among those marked with an asterisk (*)
below are present, the subject is eligible as Omenn Syndrome:

- Hepatomegaly

- Splenomegaly

- Lymphadenopathy

- Elevated IgE

- Elevated absolute eosinophil count

- *Oligoclonal T cells measured by CDR3 length or flow cytometry

- *Proliferation to PHA is reduced <50% of lower limit of normal or SI <30

- *Hypomorphic mutation in a SCID causing gene

- Low TRECS and/or the percentage of CD4+/45RA+/CD31+ or CD4+/45RA+/CD62L+ cells is
below the lower limit of normal.

Reticular Dysgenesis:

- Absence or very low number of T cells (CD3 <300/µL

- No or very low (<10% lower limit of normal) T cell response to PHA

- Severe neutropenia (absolute neutrophil count < 200 /µL) AND

- ≥2 of the following (a,b,c):

- a.) Sensori-neural deafness

- b.) Deficiency of marrow granulopoiesis on bone marrow examination

- c.) A pathogenic mutation in the adenylate kinase 2 (AK2) gene identified.

Stratum C:

Subjects who meet the following criteria and the intention is to treat with therapy other
than allogeneic HCT, primarily PEG-ADA ERT or gene therapy with autologous modified (gene
transduced) cells, are eligible for enrollment into

Stratum C:

- ADA Deficient SCID with intention to treat with PEG-ADA ERT

- ADA Deficient SCID with intention to treat with gene therapy

- X-linked SCID with intention to treat with gene therapy

- Any SCID patient previously treated with a thymus transplant (includes intention to
treat with HCT, as well as PEG-ADA ERT or gene therapy)

- Any SCID patient who received therapy for SCID deemed "non-standard" or
"investigational", including in utero procedures.

Exclusion Criteria:

-Subjects who meet any of the following exclusion criteria are disqualified from enrollment
in Strata A, B, or C of the study:

- Presence of an Human Immunodeficiency Virus (HIV) infection (by PCR) or other cause of
secondary immunodeficiency

- Presence of DiGeorge syndrome

- MHC Class I and MHC Class II antigen deficiency, and

- Metabolic conditions that imitate SCID or related disorders such as folate transporter
deficiency, severe zinc deficiency or transcobalamin deficiency.
We found this trial at
40
sites
New Orleans, Louisiana 70118
Principal Investigator: Lolie Yu, MD, MPH
Phone: 504-896-9740
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
1720 2nd Ave S
Birmingham, Alabama 35233
(205) 934-4011 
Principal Investigator: Fredrick Goldman, MD
Phone: 205-939-9285
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
3333 Burnet Avenue # Mlc3008
Cincinnati, Ohio 45229
 1-513-636-4200 
Principal Investigator: Sharat Chandra, MD
Phone: 513-636-5917
Cincinnati Children's Hospital Medical Center Patients and families from across the region and around the...
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
700 Childrens Drive
Columbus, Ohio 43205
(616) 722-2000
Principal Investigator: Rolla Abu-Arja, MD
Phone: 614-722-3582
Nationwide Children's Hospital At Nationwide Children’s, we are creating the future of pediatric health care....
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Denver, Colorado 80218
Principal Investigator: Hesham Eissa, MD
Phone: 720-777-5179
?
mi
from
Denver, CO
Click here to add this to my saved trials
Durham, North Carolina 27710
(919) 684-8111
Principal Investigator: Rebecca H. Buckley, MD
Phone: 919-684-2922
Duke University Younger than most other prestigious U.S. research universities, Duke University consistently ranks among...
?
mi
from
Durham, NC
Click here to add this to my saved trials
4650 Sunset Blvd
Los Angeles, California 90027
 (323) 660-2450
Principal Investigator: Neena Kapoor, MD
Phone: 323-361-2217
Childrens Hospital Los Angeles Children's Hospital Los Angeles is a 501(c)(3) nonprofit hospital for pediatric...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Los Angeles, California 90095
310-825-4321
Principal Investigator: Theodore Moore, MD
Phone: 310-825-6708
University of California at Los Angeles The University of California, Los Angeles (UCLA) is an...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
262 Danny Thomas Pl
Memphis, Tennessee 38105
(901) 495-3300
Principal Investigator: Ewelina K. Mamcarz, MD
Phone: 901-595-8343
St. Jude Children's Research Hospital St. Jude is unlike any other pediatric treatment and research...
?
mi
from
Memphis, TN
Click here to add this to my saved trials
South 34th Street
Philadelphia, Pennsylvania 19104
 215-590-1000
Principal Investigator: Jennifer Heimall, MD
Phone: 215-590-2549
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
4401 Penn Avenue
Pittsburgh, Pennsylvania 15224
412-692-5325
Principal Investigator: Jessie Barnum, MD
Phone: 412-692-7035
Children's Hospital of Pittsburgh of UPMC UPMC is one of the leading nonprofit health systems...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
503 494-8311
Principal Investigator: Evan Shereck, MD
Phone: 503-494-0829
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
?
mi
from
Portland, OR
Click here to add this to my saved trials
1500 E Medical Center Dr
Ann Arbor, Michigan 48109
(734) 936-4000
Principal Investigator: Mark Vander Lugt, MD
Phone: 734-936-9814
University of Michigan Health System The University of Michigan is home to one of the...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Atlanta, Georgia 30322
Principal Investigator: Shanmuganathan Chandrakasan, MD
Phone: 404-727-8877
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Bethesda, Maryland 20892
Principal Investigator: Harry Malech, MD
Phone: 301-480-6916
?
mi
from
Bethesda, MD
Click here to add this to my saved trials
Boston, Massachusetts 02115
Principal Investigator: Sung-Yun Pai, MD
Phone: 617-919-2508
?
mi
from
Boston, MA
Click here to add this to my saved trials
Calgary, Alberta
Principal Investigator: Nicola Wright, MD
Phone: 403-955-3035
?
mi
from
Calgary,
Click here to add this to my saved trials
225 E Chicago Ave
Chicago, Illinois 60611
(312) 227-4000
Principal Investigator: Sonali Chaudury, MD
Phone: 773-880-8153
Ann & Robert H. Lurie Children's Hospital of Chicago Ann & Robert H. Lurie Children
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Cleveland, Ohio 44106
Principal Investigator: Jignesh Dalal, MD
Phone: 216-844-3345
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Dallas, Texas 75390
Principal Investigator: Victor Aquino, MD
Phone: 214-456-2382
?
mi
from
Dallas, TX
Click here to add this to my saved trials
30 Prospect Ave
Hackensack, New Jersey 07601
(201) 996-2000
Principal Investigator: Alfred Gillio, MD
Phone: 201-996-5645
Hackensack University Medical Center Hackensack University Medical Center, part of the Hackensack University Health Network,...
?
mi
from
Hackensack, NJ
Click here to add this to my saved trials
6621 Fannin St
Houston, Texas 77030
(832) 824-1000
Principal Investigator: Lisa Forbes Satter, MD
Phone: 832-824-1339
Texas Children's Hospital Texas Children's Hospital, located in Houston, Texas, is a not-for-profit organization whose...
?
mi
from
Houston, TX
Click here to add this to my saved trials
Madison, Wisconsin 53705
Principal Investigator: Kenneth DeSantes, MD
Phone: 608-263-8563
?
mi
from
Madison, WI
Click here to add this to my saved trials
8701 W Watertown Plank Rd
Milwaukee, Wisconsin
(414) 955-8296
Principal Investigator: Julie An M Talano, MD
Phone: 414-456-4170
Medical College of Wisconsin The Medical College (MCW) of Wisconsin is a major national research...
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Minneapolis, Minnesota 55455
Principal Investigator: Angela Smith, MD
Phone: 612-626-2778
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: Richard J O'Reilly, MD
Phone: 646-888-2157
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials
Palo Alto, California 94304
Principal Investigator: Ami Shah, MD
Phone: 310-825-6708
?
mi
from
Palo Alto, CA
Click here to add this to my saved trials
1919 E Thomas Rd
Phoenix, Arizona 85006
(602) 933-1000
Principal Investigator: Holly Miller, MD
Phone: 602-933-0920
Phoenix Children's Hospital Phoenix Children's Hospital has provided hope, healing, and the best healthcare for...
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Rochester, Minnesota 55905
Principal Investigator: Avni Joshi, MD
Phone: 507-538-0127
?
mi
from
Rochester, MN
Click here to add this to my saved trials
Rochester, New York 14642
Principal Investigator: Jeffrey R. Andolina, MD
Phone: 585-276-3229
?
mi
from
Rochester, NY
Click here to add this to my saved trials
Saint Louis, Missouri 63104
Principal Investigator: Alan Knutsen, MD
Phone: 314-268-2700
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Saint Louis, Missouri 63110
Principal Investigator: Shalini Shenoy, MD
Phone: 314-454-6018
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Saint Petersburg, Florida 33701
Principal Investigator: Gauri Sunkersett, MD
Phone: 727-767-3513
?
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Salt Lake City, Utah 84113
Principal Investigator: David Shyr, MD
Phone: 801-662-4736
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
San Antonio, Texas 78229
Principal Investigator: Troy Quigg, DO
Phone: 210-575-7348
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
San Francisco, California 94143
Principal Investigator: Christopher C. Dvorak, MD
Phone: 415-502-0203
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Seattle, Washington 98105
Principal Investigator: Lauri M Burroughs, MD
Phone: 206-667-2396
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Valhalla, New York 10595
Principal Investigator: Allyson Flower, MD
Phone: 914-493-7997
?
mi
from
Valhalla, NY
Click here to add this to my saved trials
111 Michigan Ave NW
Washington, District of Columbia
(202) 476-5000
Principal Investigator: Blachy J. Dávila Saldaña, MD
Phone: 202-476-4561
Childrens National Medical Center As the nation’s children’s hospital, the mission of Children’s National Medical...
?
mi
from
Washington,
Click here to add this to my saved trials
Wilmington, Delaware 19899
Principal Investigator: Emi H. Caywood, MD
Phone: 302-651-5500
?
mi
from
Wilmington, DE
Click here to add this to my saved trials